Replay available

MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call

MaxCyte, Inc. (NASDAQ: MXCT) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Wed, August 6, 2025 at 4:30 PMendedReplay
MaxCyte, Inc. (MXCT) Q2 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Eric Abdaal

Ambassador to the Philippines

Meher Masood

President and Chief Executive Officer

Doug Swirsky

Chief Financial Officer

Matt Laru

Analyst, William Blair

Brandon Smith

Analyst, TD Conway

Hannah Hesley

Analyst, Stevens

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the MaxSight Second Quarter Earnings Conference Call. At this time, all participants are in listening-only mode. At the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star 1-1-1. You will hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1-1. Today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Eric Abdaal, Ambassador to the Philippines. Please go ahead. Good afternoon, everyone. Thank you for participating in today's conference call. Joining me on the call from MaxSight, we have Meher Masood, President and Chief Executive Officer, and Doug Swirsky, Chief Financial Officer. Earlier today, MaxSight released financial results for the second quarter ended June 30, 2025. A copy of the press release is available on the company's website. Before we begin, I need to read the following statement. Statements or comments made during this call may be forward-looking statements within the meaning of federal securities laws. Any statements contained in this call that relate to expectations or predictions of future events, results, or performance are forward-looking statements. Actual results may differ materially from those expressed or implied in any forward-looking statements due to a variety of factors which are discussed in detail in our SEC filings. Except as required by applicable law, the company has no obligation to publicly update any forward-looking statements, whether because of new information, future events, or otherwise. And with that, I will turn the call over to Mehar. Thank you, Eric. Good afternoon, everyone, and thank ...

More from Maxcyte, Inc.